Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03292744 |
Date of registration:
|
21/09/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly
|
Scientific title:
|
Effect of Alfacalcidol Supplementation to Respiratory Infection, Inflammatory Markers and CD4/CD8 Ratio of Indonesian Elderly |
Date of first enrolment:
|
January 10, 2017 |
Target sample size:
|
110 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03292744 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Indonesia
| | | | | | | |
Contacts
|
Name:
|
Aulia Rizka, MD |
Address:
|
|
Telephone:
|
+628125265600 |
Email:
|
dr.auliarizka@yahoo.co.id |
Affiliation:
|
|
|
Name:
|
Aulia Rizka, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Universitas Indonesia / Cipto Mangunkusumo Hospital |
|
Name:
|
Aulia Rizka, MD |
Address:
|
|
Telephone:
|
+628125265600 |
Email:
|
dr.auliarizka@yahoo.co.id |
Affiliation:
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Elderly age more than 60
- Willing to join research
Exclusion Criteria:
- In acute infection
- Using NSAID or steroid
- Liver failure
- Hypercalcemia
Age minimum:
60 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Elderly Infection
|
Frail Elderly Syndrome
|
Intervention(s)
|
Drug: Alfacalcidol
|
Primary Outcome(s)
|
upper respiratory tract infection incidence
[Time Frame: 90 days]
|
lower respiratory tract infection incidence
[Time Frame: 90 days]
|
Secondary Outcome(s)
|
T cell subset
[Time Frame: day 90]
|
antibiotic use
[Time Frame: 90 days]
|
inflammatory markers
[Time Frame: day 90]
|
Secondary ID(s)
|
VitaminDIndonesia
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|